Alembic Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alembic Pharmaceuticals conducted a postal ballot that concluded on 31 March 2026, with shareholders approving two resolutions. The first was the appointment of Mr. Rajkumar Baheti (DIN: 00332079) as a Non-Executive Non-Independent Director, passed with 99.74% votes in favour. The second was a special resolution approving payment of professional fees to Mr. Baheti, passed with 99.83% support. Out of 88,060 shareholders on record, 17.34 crore valid votes were polled (88.25% of total share base). Promoter and promoter group voted 100% in favour of both resolutions. The appointment adds a non-independent director to the board, and the separate professional fees approval suggests he will also provide services to the company beyond directorship duties.
This brings a new non-independent director associated with the promoter group onto the board, with additional professional fee arrangement — shareholders should note related-party implications. The overwhelming vote in favour signals strong promoter control, with minimal dissent from public shareholders.